Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Green, Elaine
DOB:	05-AUG-1942 (Age: 83)
Gender:	female
Address:	Studio 30N Maurice lakes M1 East Georginastad (United Kingdom)
ID:	9467-500577-4 (ECI)

Report
Date:	15-NOV-2019

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Cornbrook Medical Practice City Road 204 M3 3 Manchester (United Kingdom)

Specimen
Collected:	15-NOV-2019

Chemistry

Test	15-NOV-2019	Reference Range	Unit
Glucose [Mass/volume] in Blood	87.4	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	19.9	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	2.6 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.0	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	142.2	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.5	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	105.6	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	21.0 L	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.2	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.4	3.5 - 5.0	g/dL
Globulin [Mass/volume] in Serum by calculation	3.4 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.3	0.1 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	105.4	30 - 120	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	34.4	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	7.2 L	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	200.2 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	118.5	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	95.6	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	42.6	40 - 90	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, suggesting impaired renal function, and mildly decreased total CO₂, possibly indicating mild metabolic acidosis. Cholesterol is slightly elevated, which may increase cardiovascular risk. Low AST and globulin are noted but are of unclear clinical significance in isolation. Other parameters are within normal limits. Recommend clinical correlation and further evaluation of renal function.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated creatinine, suggesting impaired renal function, and mildly decreased total CO₂, possibly indicating mild metabolic acidosis. Cholesterol is slightly elevated, which may increase cardiovascular risk. Low AST and globulin are noted but are of unclear clinical significance in isolation. Other parameters are within normal limits. Recommend clinical correlation and further evaluation of renal function.